Trastuzumab and Interleukin-2 in Treating Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|BIOLOGICAL: aldesleukin|OTHER: laboratory biomarker analysis|OTHER: pharmacological study
Sponsor: National Cancer Institute (NCI)